Macrophage Mer Tyrosine Kinase (MerTK) has also been shown to play an indirect role in HSC activation in NASH, notably by inducing ERK1/2 phosphorylation and TGF-β1 release by KCs after Gas6 stimulation. Here, MERTK is linked to metabolic dysfunction-associated steatohepatitis.